共 119 条
[11]
An J(2018)Diagnosis, staging, and management of hepatocellular carcinoma: 2018 practice guidance by the American Association for the Study of Liver Diseases Hepatology 68 5142-5151
[12]
Lim YS(2021)MRI is the most commonly used imaging modality for HCC screening at a tertiary care transplant center Abdom Radiol (NY) 46 744-758
[13]
Tzartzeva K(2019)Abbreviated MRI protocols for the abdomen Radiographics 39 179-190
[14]
Obi J(2017)Hepatocellular carcinoma detection: diagnostic performance of a simulated abbreviated MRI protocol combining diffusion-weighted and T1-weighted imaging at the delayed phase post gadoxetic acid Abdom Radiol (NY) 42 49-618
[15]
Rich NE(2019)HCC screening: assessment of an abbreviated non-contrast MRI protocol Eur Radiol Exp 3 610-724
[16]
Singal A(2014)Noncontrast MRI with diffusion-weighted imaging as the sole imaging modality for detecting liver malignancy in patients with high risk for hepatocellular carcinoma Magn Reson Imaging 32 718-6013
[17]
Volk ML(2020)Non-enhanced magnetic resonance imaging as a surveillance tool for hepatocellular carcinoma: comparison with ultrasound J Hepatol 72 6003-4163
[18]
Waljee A(2020)Gadoxetate-enhanced abbreviated MRI is highly accurate for hepatocellular carcinoma screening Eur Radiol 30 4150-535
[19]
Lok AS(2020)Comparison of diagnostic performance of non-contrast MRI and abbreviated MRI using gadoxetic acid in initially diagnosed hepatocellular carcinoma patients: a simulation study of surveillance for hepatocellular carcinomas Eur Radiol 30 527-2311
[20]
Sterling RK(2019)Gadoxetate-enhanced abbreviated MRI for hepatocellular carcinoma surveillance: preliminary experience Radiol Imaging Cancer 1 2302-493